Spots Global Cancer Trial Database for The Study Of An Oral Drug Called A Radiation Sensitizer In Patients With Newly Diagnosed Small Cell Lung Cancer (SCLC)
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: The Study Of An Oral Drug Called A Radiation Sensitizer In Patients With Newly Diagnosed Small Cell Lung Cancer (SCLC)
Official Title: A Phase II Trial of Twice Daily Oral Topotecan as a Radiation Sensitizer With Twice Daily Radiotherapy for Newly Diagnosed Small Cell Lung Cancer
Study ID: NCT00043862
Interventions
Study Description
Brief Summary: This study will gather information on the effectiveness and safety of a treatment program for small cell lung cancer (SCLC) that uses an FDA approved chemotherapy combination, radiation therapy, and an oral investigational drug that may enhance the effects of radiation therapy. Study patients will receive two additional courses of the standard chemotherapy combination after completing radiation therapy.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
GSK Investigational Site, Phoenix, Arizona, United States
GSK Investigational Site, Little Rock, Arkansas, United States
GSK Investigational Site, Bakersfield, California, United States
GSK Investigational Site, Fountain Valley, California, United States
GSK Investigational Site, Los Angeles, California, United States
GSK Investigational Site, Gainesville, Florida, United States
GSK Investigational Site, Indianapolis, Indiana, United States
GSK Investigational Site, Lexington, Kentucky, United States
GSK Investigational Site, New Orleans, Louisiana, United States
GSK Investigational Site, New Orleans, Louisiana, United States
GSK Investigational Site, Shreveport, Louisiana, United States
GSK Investigational Site, Scarborough, Maine, United States
GSK Investigational Site, Springfield, Massachusetts, United States
GSK Investigational Site, Duluth, Minnesota, United States
GSK Investigational Site, Minneapolis, Minnesota, United States
GSK Investigational Site, Robbinsdale, Minnesota, United States
GSK Investigational Site, Saint Louis, Missouri, United States
GSK Investigational Site, St. Louis, Montana, United States
GSK Investigational Site, Albuquerque, New Mexico, United States
GSK Investigational Site, Raleigh, North Carolina, United States
GSK Investigational Site, Akron, Ohio, United States
GSK Investigational Site, Cincinnati, Ohio, United States
GSK Investigational Site, Cleveland, Ohio, United States
GSK Investigational Site, Toledo, Ohio, United States
GSK Investigational Site, Fort Worth, Texas, United States
GSK Investigational Site, San Antonio, Texas, United States
GSK Investigational Site, Green Bay, Wisconsin, United States
GSK Investigational Site, La Crosse, Wisconsin, United States
GSK Investigational Site, Madison, Wisconsin, United States
GSK Investigational Site, Milwaukee, Wisconsin, United States
GSK Investigational Site, Wausau, Wisconsin, United States
Contact Details
Name: GSK Clinical Trials, MD
Affiliation: GlaxoSmithKline
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
